The argument of the authors goes as follows: DREDD is ubiquitylated by DIAP2; DREDD [D44] is poorly ubiquitylated and is functioning like the wild-type protein when overexpressed (as noted above, not all functions of DREDD have been investigated); DREDD mutants are more susceptible to infection and fail to express AMP genes, therefore ubiquitylation is important. The weak point is that the authors cannot exclude that DREDD[D44] may be affecting another as yet possibly nondescribed function of DREDD and that is not linked to ubiquitylation. To play the devil's advocate, one might think that ubiquitylation is just a secondary consequence of DREDD signaling that occurs as a consequence of its main ascribed functions, namely IMD and Relish cleavage. This reviewer proposes some steps to address these points. From published data, it is not clear whether the diap2 null phenotype is as strong as that of null imd, FADD, ird5, kenny, or Relish mutants. Indeed, this reviewer notes that Huh et al (2007) observed that diap2 null mutant flies were dying at the same rate as imd [1] flies, which are hypomorphic and die slower than null imd (or FADD, ird5, kenny, Relish) flies. Here, the authors show that dredd [D44] mutant flies also succumb slower to a septic injury with Ecc15 than diap2 [7c] mutants. This observation alone suggests that all of the effects of DIAP2 are not mediated through the decreased ubiquitylation of DREDD [D44] . If the effects of DREDD[D44] were mediated by another mechanism than DIAP2-dependent ubiquitylation, then one would expect that the double mutant diap2[7c]-dredd[D44] would display a stronger phenotype of susceptibility to bacterial infections than the cognate single mutants. This reviewer would advise using a weakly pathogenic strain such as E. coli rather than more aggressive bacteria such as ECC15 or E. cloacae that have been used so far so as to increase the resolution of the survival assay. Also, essential controls were missing in all survival experiments. These include a strong imd pathway mutant with its cognate wild-type in the same genetic background, biochemically null homozygous and hemizygous dredd mutants, and, of course, dredd[D44] hemizygous flies.
The second point is that the authors did not address a key point, that is to determine whether IMD cleavage by DREDD[D44] AND its subsequent ubiquitylation by DIAP2 is affected or not. Indeed, the weak phenotype of dredd[D44] is compatible with this possibility. Ideally, the authors should also test whether Relish still gets phosphorylated in dredd[D44] mutant flies (Erturk-Hasdemir, 2009). The third point is that Fig. 5D is not overwhelmingly convincing. This reviewer notes a compression of the most critical lane: wt at 15'. It is thus difficult to have a good reference point for what should be thorough cleavage as the intensity of this band may be artificially enhanced. How many times has this experiment been performed? Gels should be scanned and quantification of cleavage performed. Also, a relevant negative control such as a dredd null mutant should be used. The lack of cleavage of Relish in diap2 mutants has not been observed in all laboratories (see Kleino et al., EMBO J. (2005) ); thus, it does not represent an adequate control. Fourth, an important question is to determine whether ubiquitylation of DREDD is required for IMD cleavage as noted above. Paquette et al. (Mol. Cell (2010) ) have reported that IMD ubiquitylation occurs already one minute after an immune stimulus. The authors should perform a similarly detailed kinetics analysis to determine whether DREDD gets ubiquitylated before or after IMD. This reviewer is aware that it may be technically difficult to answer the question as to whether DREDD gets modified before IMD but the authors can at least exclude the possibility that it gets ubiquitylated afterwards. Another strategy to resolve this question might be to take advantage of the DIAP2 [C149G/C249G] property of not binding to IMD but binding to DREDD. Should this mutant protein still be able to mediate the ubiquitylation of DREDD, then it would be possible to devise a rescue experiment of a dredd mutant with this DIAP2 [C149G/C249G] double mutant protein to determine whether IMD still gets cleaved when it can no longer be itself ubiquitylated. In cell culture, this would entail inhibiting the expression of the endogenous gene, e.g., by targeting its 3'UTR (Paquette et al. (2010)) and expressing the mutant protein with another 3'UTR. The best would be to do this in flies. Of note, this is a suggestion, not a requirement.
Minor points: 1. p5: introduction, end of paragraph: not all loss-of function mutants of imd pathway display the SAME phenotype. SIMILAR would be more accurate.
2. It is somewhat surprising that the authors do not mention in the introduction negative regulation of ubiquitylation by ubiquitin-proteases, e.g., dUSP36 in Drosophila 3. Results: end of first paragraph: INDICATES that DIAP2-mediated... Indicate is too strong a word as the authors have not shown that the RING mutant DIAP2 is as stable as wild-type DIAP2. Also, the nature of the RING mutation is not indicated anywhere. Figure 2E : DREDD p10 is found after FADD (and DREDD) immunoprecipitation, but not in the lysate although p20/P10 is detectable (and is found with the same intensity as p10 in immunoprecipitates). Can the authors comment on this result (not in the final manuscript)?
4.
5. When overexpressing tagged DREDD, is it know whether it is sufficient to activate the IMD pathway (AMP expression) as apparently it is sufficient to trigger Relish cleavage (Fig. 3G)? 6. A major point of the paper is that DREDD[D44] can cleave Relish when overexpressed. Can they really exclude that DREDD requires ubiquitylation for activation to cleave its substrates when it is present in normal physiological concentrations? For instance, overexpressed DREDD dimerizes. Can the authors exclude that the effects they observe, e.g., cleavage of Relish in Fig. 3G is not mediated by dimerization to the wild-type endogenous DREDD protein? The C>A control might exclude this possibility. Yet, have the authors shown that the C>A DREDD mutant can still dimerize with wild-type DREDD? In the same figure, how can the author explain the appearance of cleaved DREDD after zVAD-FMK treatment if cleavage is the result of autoprocessing as mentioned for Fig. 3D ? A cleaner demonstration would be to inhibit endogenous DREDD expression by RNAi and express the DREDD[D44] mutant protein (see last major point for strategy) 7. the basal expression of IMD-dependent antimicrobial peptides is usually very low. Thus, any conclusion based on this may not be highly significant and is not really worth mentioning.
8. To induce Diptericin expression by a mere two-fold factor following an immune challenge is indicative of major technical problems (the authors should check the Leulier reference they cite: the induction there is at least 50 fold even though it is difficult to provide an exact figure from just looking at a western blot). First, why did the authors inject such huge quantities of a rather pathogenic bacterium, Ecc15, when simple pricking is sufficient to kill them (Fig. 1A) ? The authors would most likely be much better off just challenging with killed bacteria as they cannot exclude that the massive injection of bacteria actually perturbs the immune response. Just a classical challenge with E. coli would do the trick. A second problem is that the authors use 20-40 flies per data point. In this reviewers' laboratory, five flies at most are used per data point and the cDNAs have to be diluted as too high cDNA concentrations actually tend to inhibit the qPCR reaction. This can easily be checked by performing serial dilutions of the same cDNA samples and monitoring the expression of any gene: nonlinearity is observed at high cDNA concentrations. This is a thorough and interesting study, for the first time showing the role of ubiquitylation of the Drosophila caspase Dredd in Relish activation. The results helps explain some of the complexities in this Drosophila model for NF-B activation, and thereby potentially also for the corresponding human system. Before the paper is published, the authors have to resolve the apparent contradiction between the results shown in Fig. 3G , that the Dredd[D44] mutant is fully competent to cleave Relish, and Fig.  5D , showing that Dredd[D44] has lost this capacity. Or at least they have to give a plausible explanation that this reader can understand. Could it be that the result in Fig. 3G is an artefact of the overexpression system? That would point to a general weakness of the paper; that many of the results are obtained in S2 cells under relatively unphysiological conditions. Be that as it may; these are the tools we have and in general the results make sense and they are corroborated by in vivo results, with the mentioned exception.
I am surprised by the very modest relative induction of Diptericin expression caused by Erwinia: about two-fold only. In our hands, and in the published literature, induction is usually 1-2 orders of magnitude. This could indicate that the baseline induction level is already unusually high in these experiments. This could also explain why Dredd and Iap2 mutants have such a strong effect on Dpt and AttD expression even in uninfected animals. On the other hand, AttD is still induced 30-fold by the bacteria. Maybe there is some problem with Dpt qtPCR? The apparent lack of effect of the Iap mutant on Dpt induction also points in that direction. I note that the latter oddity is not correctly described in the text. Are these results reproducible and properly controlled? If they are, these problems should be commented in the text. If not, repeat Dpt quantification.
Flybase genetic nomenclature should be adhered to. The prefix "d" or "D" (for "Drosophila") is banned, for good reasons. Hence Iap2, not Diap2 or diap2, and it should be BG4, not dFadd and Dredd, not dredd. Commonly used synonyms could be mentioned in the beginning, to avoid confusion. A consistent nomenclature is important, not least for beginners that have not yet learned the sloppy jargon of the field.
It is misleading to describe diaminopimelic-type (DAP-type) peptidoglycan as "the Gram-negative cell wall component" (p. 4). DAP-type peptidoglycan is also found in many Gram-positive bacteria. Indeed, many important Gram-positive insect pathogens and commensals such as the Bacillus species and many lactobacilli have DAP-type peptidoglycan. The Gram-positive bacteria are probably not monophyletic and they include a wide variety of cell wall structures. For this reason, the statement on p. 13 that Dredd and Iap2 mutants "were fully resistant to infection by Grampositive bacteria (data not shown)" is too much of a generalization. Which bacteria were actually tested?
In the last paragraph on p. 13, I miss a reference to the figure (Fig. 5D? ).
Referee #3 (Remarks to the Author):
In the submitted manuscript, Meinander et al. characterized a DIAP2-dependent ubiquitylation of the caspase DREDD (a homolog of caspase8) as a required step in the transmission of the signal after activation of innate immune receptors.
While the role of IAPs in caspase-mediated apoptosis is well established, their role in regulating caspases in non-apoptotic pathways is less well understood -both in invertebrates and in mammals. Previous studies have shown that DIAP2 is specifically required for the control of the Imd signaling pathways, acting above the TAK1/TAB2 complex in the activation of downstream signaling. Further studies from the Meier lab and others have shown that DIAP2 binds and ubiquitylates Imd.
Through a set of ex vivo and in vivo experiments, the authors convincingly demonstrates that DIAP2 also binds through partially overlapping binding sites to DREDD and leads its ubiquitylation, which appears to be necessary for its activity. Mechanistically, Meinander and colleagues show that DIAP2 (and dFADD) binds to the DED1 domain of DREDD. They could further underline the importance of the ubiquitylation of DREDD by characterization of a mutant (G120R) in the DED1 domain which is not efficiently ubiquitylated. Taken together, the study makes an important contribution towards understanding of how IAPs regulate non-apoptotic pathways -and might lay the foundation to understand how TNF-signaling might be regulate also in higher vertebrats.
The authors present a round story which is overall very well controlled. They provide evidence for a role of DIAP2-dependent ubiquitylation of DREDD both on the molecular level and also demonstrate that ubiquitylation-deficient (or diminished) mutants of DREDD and incapable of mounting an efficient immune response. I have a few questions/concerns outlined below but otherwise I would recommend publication in EMBO J.
1. Is there any evidence for which kind of ubiquitylation is required for DREDD activation. The authors state that DREDD show a "basal" level of ubiquitylation; is this though a different linkage that the signal-induced ubiquitylation? 2. A recent study has shown that DREDD is similarly required for PGRL-LC induced activation of JNK. Is DIAP2-dependent Ub-modification of DREDD required for the activation of JNK-signaling through PGRL-LCx?
Other points:
1. Why is the interaction DREDD-DREDD wt weaker than DREDD G120R ( 1
Response to reviewer's comments on manuscript EMBOJ-2011-79526
We would like to thank you and the referees for the helpful comments and constructive criticisms. We have responded to them in full with new and improved experiments, which have significantly improved our manuscript.
Overall, our additional experiments support and expand our previous observations. We have also included experiments that were not requested by the reviewers, but which we felt significantly advance the insights into the regulation of DREDD-dependent signalling.
Our new observations include:
• We have examined whether impaired ubiquitylation of DREDD affects IMD ubiquitylation, which we previously have shown to require DREDD-mediated cleavage. Intriguingly, we found that IMD is not ubiquitylated in dredd D44 mutant flies (new Fig. 5C ), which indicates that cleavage of IMD is impaired in these animals. Given that the loss-of-function mutant DREDD D44 readily binds to DIAP2 but fails to be ubiquitylated in a stimulus-dependent manner, our new data suggest that ubiquitylation of DREDD is required for its full activation under physiological conditions.
• Consistent with the notion that DREDD ubiquitylation is an early event, we find that ubiquitylation of DREDD occurs already within 1 minute of pathway activation (new Fig. 1F ).
• We have addressed the importance of individual BIR domains and found that both BIR2 and BIR3 domains are required for IMD signaling (new 1G ).
• In addition, we provide an extensive hetero-and homodimerisation study (new Fig.  3G ), demonstrate that DREDD D44 's catalytic centre is intact and can process Relish in mammalian cells, and demonstrate that TAK1-mediated JNK activation is also impaired in dredd D44 mutant flies (new Fig. 5D ).
• We have corrected all the technical shortcomings and include new and improved data sets (Fig. 5A, B and E), which corroborate and expand our earlier findings.
Together, our data support the notion that ubiquitylation of DREDD is required for its activation, promoting IMD and Relish cleavage, IMD ubiquitylation and pathway activation.
Please find below a point-by-point response to the reviewers' comments, with the reviewers comments in blue boxes and our response in plain text. We have included the relevant new data for convenience:
Referee #1 (Remarks to the Author):
This interesting article reports that: Fig. 5C ), which indicates that cleavage of IMD is impaired in these animals. Given that DREDD D44 readily binds to DIAP2 but fails to be ubiquitylated in a stimulus-dependent manner, our new data suggest that ubiquitylation of DREDD is required for its activation under physiological conditions. This also places ubiquitylation of DREDD epistatic to IMD cleavage, corroborating its importance in IMD signaling. Consistent with the notion that DREDD ubiquitylation is an early event, we find that ubiquitylation of DREDD occurs already within 1 minute of pathway activation (new Fig. 1F ). We have amended our manuscript to include these new data. The argument of the authors goes as follows: DREDD is ubiquitylated by DIAP2; DREDD [D44] is poorly ubiquitylated and is functioning like the wild-type protein when overexpressed (as noted above, not all functions of DREDD have been investigated); DREDD mutants are more susceptible to infection and fail to express AMP genes, therefore ubiquitylation is important. The weak point is that the authors cannot exclude that DREDD[D44] may be affecting another as yet possibly nondescribed function of DREDD and that is not linked to ubiquitylation. To play the devil's advocate, one might think that ubiquitylation is just a secondary consequence of DREDD signaling that occurs as a consequence of its main ascribed functions, namely IMD and Relish cleavage. This reviewer proposes some steps to address these points: While we cannot rule out the possibility that the D44 mutation affects another as yet possibly non-described function of DREDD, our data are consistent with a model whereby ubiquitylation of DREDD contributes to its activation, allowing persistent oligomerisation and full activation of the enzyme. This in turn leads to cleavage of IMD and Relish. We have tested every aspect of DREDD function and found that dimerisation, FADD-binding, DIAP2-binding and the catalytic centre are not affected by the G120R mutation (Fig. 3A-I) . The sole detectable effect of this mutation is its interference with DIAP2-mediated ubiquitylation of DREDD. There is always room for additional interpretations of our data. However, in the absence of any other possible explanation, we propose a model whereby ubiquitylation of DREDD contributes to its activation. This notion is supported by a recent study indicating that mammalian caspase-8 is activated in a Ub-and p62-dependent manner (Jin et al., Cell. 2009 May 15;137(4):721-35). Thus, the Ub chains on DREDD are likely to function as anchor points for a Ub-receptor, which presumably helps dimerisation and activation of DREDD. We have toned down our language to leave room for additional explanations.
From published data, it is not clear whether the diap2 null phenotype is as strong as that of null imd, FADD, ird5, kenny, or Relish mutants. We would like to indicate that Leulier et al. (Fig. 2D in We have addressed this point by determining the ubiquitylation status of IMD in dredd D44 flies. As indicated in our response to the first point above, we find that IMD fails to be ubiquitylated in dredd D44 mutant flies. To measure the impact on dTAK1 activation, we exposed wild-type and dredd D44 flies to septic injury and measured JNK-mediated induction of puckered gene expression. dTAK1 reportedly activates JNK following septic injury. As shown in Fig. 5D , we found that induction of puckered expression was impaired in dredd D44 flies, as would be expected given that IMD ubiquitylation is required for dTAK1-mediated activation of JNK.
New Fig. 5D .
The third point is that Fig. 5D is not overwhelmingly convincing. This reviewer notes a compression of the most critical lane: wt at 15'. It is thus difficult to have a good reference point for what should be thorough cleavage as the intensity of this band may be artificially enhanced. How many times has this experiment been performed? Gels should be scanned and quantification of cleavage performed. Also, a relevant negative control such as a dredd null mutant should be used. The lack of cleavage of Relish in diap2 mutants has not been observed in all laboratories (see Kleino et al., EMBO J. (2005)); thus, it does not represent an adequate control. We have followed the reviewer's suggestion and provide an improved immunoblot analysis that includes additional controls and genotypes (new Fig 5E) . Shown is a representative immunoblot of three independent repeats. From this data it is clear that dredd D44 (2010)) have reported that IMD ubiquitylation occurs already one minute after an immune stimulus. The authors should perform a similarly detailed kinetics analysis to determine whether DREDD gets ubiquitylated before or after IMD. This reviewer is aware that it may be technically difficult to answer the question as to whether DREDD gets modified before IMD but the authors can at least exclude the possibility that it gets ubiquitylated afterwards. We have addresses this important issue as outlined above. See our response to point 1. Indeed, we find that ubiquitylation of DREDD occurs already within 1 minute of pathway activation (new Fig. 1F ). We have amended our manuscript to include these new data. It appears therefore, that DREDD ubiquitylation occurs very early during pathway activation and at a similar time as ubiquitylation of IMD.
New Fig. 1F .
Another strategy to resolve this question might be to take advantage of the DIAP2 [C149G/C249G] property of not binding to IMD but binding to DREDD. Should this mutant protein still be able to mediate the ubiquitylation of DREDD, then it would be possible to devise a rescue experiment of a dredd mutant with this DIAP2 [C149G/C249G] double mutant protein to determine whether IMD still gets cleaved when it can no longer be itself ubiquitylated. In cell culture, this would entail inhibiting the expression of the endogenous gene, e.g., by targeting its 3'UTR (Paquette et al. (2010)) and expressing the mutant protein with another 3'UTR. The best would be to do this in flies. Of note, this is a suggestion, not a requirement. We have followed the suggestion of this reviewer and provide new data comparing single and double BIR-mutant animals. To evaluate the contribution of individual BIR domain of DIAP2, we generated transgenic flies using germ-line-specific phiC31 integration into pre-defined landing sites, which allows accurate comparison between mutants. DIAP2 transgenes encoding DIAP2 mutants with amino acid (aa) substitutions in either the BIR2 (D163A) or BIR3 (D263A) domain (Ribeiro et al, 2007) efficiently rescued the sensitivity to Ecc15 infection seen in diap2 7c mutant flies. In contrast, double mutants carrying a substitution in BIR2 and BIR3 (D163A/D263A) failed to provide protection from Ecc15 septic injury (Fig. 1B) .
Minor points: 1. p5: introduction, end of paragraph: not all loss-of function mutants of imd pathway display the SAME phenotype. SIMILAR would be more accurate. We changed the corresponding sentence accordingly.
2. It is somewhat surprising that the authors do not mention in the introduction negative regulation of ubiquitylation by ubiquitin-proteases, e.g., dUSP36 in Drosophila. We have corrected this shortcoming. .. Indicate is too strong a word as the authors have not shown that the RING mutant DIAP2 is as stable as wild-type DIAP2. Also, the nature of the RING mutation is not indicated anywhere. We apologize for failing to provide the reference of the ms in which it was shown that the RING mutant DIAP2 is as stable as wild-type DIAP2. We have corrected this oversight (Ribeiro et al., J Cell Biol. 2007 Dec 31;179(7):1467-80). For this study we have used the C>Y mutation that abrogates the E3 ligase activity of DIAP2. This mutation removes the zinc coordinating cysteine required for the proper folding of the RING domain.
4. Figure 2E : DREDD p10 is found after FADD (and DREDD) immunoprecipitation, but not in the lysate although p20/P10 is detectable (and is found with the same intensity as p10 in immunoprecipitates). Can the authors comment on this result (not in the final manuscript)? The p10 is actually present and visible in a longer exposure. It is noteworthy that the p20/p10, which lacks the pro-domain) is not co-purified with FADD because DREDD requires the prodomain for FADD-binding. The p10 co-purifies with full-length DREDD due to the dimeric nature of DREDD. The actual size of the p10 migrates slower on the SDS page than its predicted size due to the addition of the tag.
5. When overexpressing tagged DREDD, is it know whether it is sufficient to activate the IMD pathway (AMP expression) as apparently it is sufficient to trigger Relish cleavage (Fig. 3G) 7821-31) . In this study, we found that the AMP induction achieved by over-expressing DREDD is about 6% of the one that is obtained following septic injury. This is consistent with the notion that in addition to cleavage, Relish also needs to be phosphorylated in order to efficiently induce AMP gene expression (Ertürk-Hasdemir, Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9779-84).
6. A major point of the paper is that DREDD[D44] can cleave Relish when overexpressed. Can they really exclude that DREDD requires ubiquitylation for activation to cleave its substrates when it is present in normal physiological concentrations? For instance, overexpressed DREDD dimerizes. Can the authors exclude that the effects they observe, e.g., cleavage of Relish in Fig. 3G is not mediated by dimerization to the wild-type endogenous DREDD protein? The C>A control might exclude this possibility. Yet, have the authors shown that the C>A DREDD mutant can still dimerize with wild-type DREDD? In the same figure, how can the author explain the appearance of cleaved DREDD after zVAD-FMK treatment if cleavage is the result of autoprocessing as mentioned for Fig. 3D ? A cleaner demonstration would be to inhibit endogenous DREDD expression by RNAi and express the DREDD[D44] mutant protein (see last major point for strategy) We would like to thank this reviewer for the input. Indeed, our new data suggest that DREDD activation requires ubiquitylation under physiological conditions. The over-expression experiment was designed to assess whether the G120R mutation influences the catalytic centre of DREDD, for example by distorting the catalytically active cysteine, or by interfering with substrate entry. Given that DREDD can cleave Relish under these conditions, it appears that the G120R mutation does not affect the catalytic parameter of DREDD. Therefore, the catalytic cysteine as well as substrate entry appear not to be affected by the G120R mutation. This is not entirely surprising given that the G120R substitution mutation is positioned in the pro-domain. Nevertheless it was important to test. The over-expression assay is a functionality and integrity test to assess the enzymatic activity of the enzyme.
Can the authors exclude that the effects they observe, e.g., cleavage of Relish in Fig. 3G is not mediated by dimerization to the wild-type endogenous DREDD protein? The observation that the C>A mutant of DREDD, which bears no catalytic activity, fails to cleave Relish, suggests that Relish cleavage is not mediated by dimerization to the wild-type endogenous DREDD protein. We also include an extensive dimerization assays (Fig. 3F and new 3G, see below) indicating that C>A and G120R mutant DREDD hetero-and homodimerize like WT DREDD. Further, upon over-expression mutant DREDD cleaved Relish like its wild-type counterpart, both in Drosophila S2 cells (Fig. 3H) as well as mammalian 293T cells (see below). From this, it seems rather unlikely that DREDD D44 promotes cleavage of Relish via endogenous WT DREDD.
New Fig. 3G Rebuttal Figure. Relish cleavage in 293T cells 7. the basal expression of IMD-dependent antimicrobial peptides is usually very low. Thus, any conclusion based on this may not be highly significant and is not really worth mentioning. We have followed the suggestion and removed the data.
8. To induce Diptericin expression by a mere two-fold factor following an immune challenge is indicative of major technical problems (the authors should check the Leulier reference they cite: the induction there is at least 50 fold even though it is difficult to provide an exact figure from just looking at a western blot). First, why did the authors inject such huge quantities of a rather pathogenic bacterium, Ecc15, when simple pricking is sufficient to kill them (Fig. 1A) ? The authors would most likely be much better off just challenging with killed bacteria as they cannot exclude that the massive injection of bacteria actually perturbs the immune response. Just a classical challenge with E. coli would do the trick. We replaced Fig. 5A with new improved experiments, which shows that expression of attacin D and diptericin are induced approximately 600 and 200 fold, respectively, in wild-type flies. Error bars indicate SEM from three independent experimental repeats using at least 20 flies per repeat. Most likely, the low level of induction of our previous experiment was due to a smoldering bacterial infection in our fly stocks. This has now been cleared up. Presumably, this increased the background values, reducing the fold-induction. We have corrected this in our revised ms. Importantly, no other experiment was affected by this potential infection. With regards to the protocol used, we followed the one recommended by Bruno Lemaitre. This is a thorough and interesting study, for the first time showing the role of ubiquitylation of the Drosophila caspase Dredd in Relish activation. The results helps explain some of the complexities in this Drosophila model for NF-&#x03BA;B activation, and thereby potentially also for the corresponding human system. Before the paper is published, the authors have to resolve the apparent contradiction between the results shown in Fig. 3G , that the Dredd[D44] mutant is fully competent to cleave Relish, and Fig. 5D , showing that Dredd[D44] has lost this capacity. Or at least they have to give a plausible explanation that this reader can understand. Could it be that the result in Fig.  3G is an artefact of the overexpression system? That would point to a general weakness of the paper; that many of the results are obtained in S2 cells under relatively unphysiological conditions. Be that as it may; these are the tools we have and in general the results make sense and they are corroborated by in vivo results, with the mentioned exception. We would like to thank this reviewer to clarify this point. Unfortunately, this wasn't properly spelled out in our first submission. Our data suggest that DREDD activation requires ubiquitylation under physiological conditions. The over-expression experiment was designed to assess whether the G120R mutation influences the inherent catalytic activity of DREDD, for example by distorting the catalytically active centre, or by interfering with substrate entry. Given that DREDD D44 can cleave Relish under over-expression conditions, it appears that the G120R mutation does not affect the catalytic parameter of DREDD. Therefore, the catalytic cysteine as well as substrate entry appear not to be affected by the G120R mutation. This is not entirely surprising given that the G120R substitution mutation is positioned in the prodomain. Nevertheless it was important to test. The over-expression assay is a functionality and integrity test to assess the inherent enzymatic activity of the enzyme. Under physiological conditions, however, activation of DREDD appears to require ubiquitin-assisted dimerisation. This notion is supported by a recent study indicating that mammalian caspase-8 is activated in a Ub-and p62-dependent manner (Jin et al., Cell. 2009 May 15;137(4):721-35). Thus, the Ub chains on DREDD are likely to function as anchor points for a Ub-receptor, which presumably helps dimerisation and activation of DREDD. We have toned down our language to leave room for additional explanations.
I am surprised by the very modest relative induction of Diptericin expression caused by Erwinia: about two-fold only. In our hands, and in the published literature, induction is usually 1-2 orders of magnitude. This could indicate that the baseline induction level is already unusually high in these experiments. This could also explain why Dredd and Iap2 mutants have such a strong effect on Dpt and AttD expression even in uninfected animals. On the other hand, AttD is still induced 30-fold by the bacteria. Maybe there is some problem with Dpt qtPCR? The apparent lack of effect of the Iap mutant on Dpt induction also points in that direction. I note that the latter oddity is not correctly described in the text. Are these results reproducible and properly controlled? If they are, these problems should be commented in the text. If not, repeat Dpt quantification. We replaced Fig. 5A with new improved experiments, which shows that expression of attacin D and diptericin are induced approximately 600 and 200 fold, respectively, in wild-type flies. Error bars indicate SEM from three independent experimental repeats using at least 20 flies per repeat. Most likely, the low level of induction of our previous experiment was due to a smoldering bacterial infection in our fly stocks. This has now been cleared up. Presumably, this increased the background values, reducing the fold-induction. We have corrected this in our revised ms. Importantly, no other experiment was affected by this potential infection.
New Fig. 5A
Flybase genetic nomenclature should be adhered to. The prefix "d" or "D" (for "Drosophila") is banned, for good reasons. Hence Iap2, not Diap2 or diap2, and it should be BG4, not dFadd and Dredd, not dredd. Commonly used synonyms could be mentioned in the beginning, to avoid confusion. A consistent nomenclature is important, not least for beginners that have not yet learned the sloppy jargon of the field. We have corrected our ms to indicate the Flybase nomenclature. We now provide all given names. However, due to didactical reasons and accessibility to non-fly people we prefer to use DIAP2 and dFADD (instead of IAP2 and BG4). Particularly, IAP2 actually refers to mammalian cIAP1 (http://www.genecards.org/cgi-bin/carddisp.pl?gene=BIRC2), which might confuse readers. From my own personal experience talking to non-fly people, the material is made much more accessible if names are used that non-fly people can relate to. We are more than happy to change this should this reviewer and editor insist on using IAP2 and BG4.
It is misleading to describe diaminopimelic-type (DAP-type) peptidoglycan as "the Gramnegative cell wall component" (p. 4). DAP-type peptidoglycan is also found in many Grampositive bacteria. Indeed, many important Gram-positive insect pathogens and commensals such as the Bacillus species and many lactobacilli have DAP-type peptidoglycan. The Grampositive bacteria are probably not monophyletic and they include a wide variety of cell wall structures. For this reason, the statement on p. 13 that Dredd and Iap2 mutants "were fully resistant to infection by Gram-positive bacteria (data not shown)" is too much of a generalization. Which bacteria were actually tested? We apologize for this oversight. We have used the Gram-positive bacteria M. Luteus. We have corrected our ms accordingly.
In the last paragraph on p. 13, I miss a reference to the figure (Fig. 5D?) . We have corrected this oversight.
Through a set of ex vivo and in vivo experiments, the authors convincingly demonstrates that DIAP2 also binds through partially overlapping binding sites to DREDD and leads its ubiquitylation, which appears to be necessary for its activity. Mechanistically, Meinander and colleagues show that DIAP2 (and dFADD) binds to the DED1 domain of DREDD. They could further underline the importance of the ubiquitylation of DREDD by characterization of a mutant (G120R) in the DED1 domain which is not efficiently ubiquitylated. Taken together, the study makes an important contribution towards understanding of how IAPs regulate nonapoptotic pathways -and might lay the foundation to understand how TNF-signaling might be regulate also in higher vertebrats. activation of JNK. Is DIAP2-dependent Ub-modification of DREDD required for the activation of JNK-signaling through PGRL-LCx? Indeed this seems to be the case as JNK activation (as measured by expression of puckered, see below) is blocked in dredd D44 mutant flies. This data is consistent with the observation that IMD ubiquitylation, which is required for TAK1-mediated activation of JNK, is lost in dredd D44 mutant animals (new Fig. 5D ). Therefore, we conclude that DIAP2-dependent ubiquitylation of DREDD is an upstream event. Consistently, we find that ubiquitylation of DREDD occurs already within 1 minute of pathway activation (new Fig. 1F) . Fig. 5D . puckered expression in response to septic injury with Ecc15 (black bars). Shown is a representative experiment of three repeats. Note, septic injury with Ecc15 results in a moderate but significant increase in puckered expression, which is lost in dredd B118 , dredd Other points:
1. Why is the interaction DREDD-DREDD wt weaker than DREDD G120R (Fig. 3F) ? Additional interaction studies (see Fig. 3F and G) indicated that wt and mutant DREDD interacted with each other with comparable efficiencies. Shown are representative immunoblots of at least three experiments.
2. Fig. 5 has no error bars. Statistical tests should be added. We have corrected this shortcoming.
3. Why are Dipt levels in DIAP2-7c almost as high as in wt (Fig. 5) ? We replaced Fig. 5A with new improved experiments, which shows that expression of attacin D and diptericin are induced approximately 600 and 200 fold, respectively, in wild-type flies.
Error bars indicate SEM from three independent experimental repeats using at least 20 flies per repeat. Most likely, the low level of induction of our previous experiment was due to a smoldering bacterial infection in our fly stocks. This has now been cleared up. Presumably, this increased the background values, reducing the fold-induction. We have corrected this in 13 our revised ms. Importantly, no other experiment was affected by this potential infection.
New Fig. 5A 
